Concepedia

Naja Nyffenegger

NN

7

Publications

221

Citations

7

H-Index

2012

Active since

Affiliations

Vifor Pharma (United States)(Current)

Vifor Pharma (Switzerland)

Naja Nyffenegger is an author at Vifor Pharma (United States) specializing in medicine, metabolism, and diabetes.

ORCID

Top concepts

Publications per year

2012–2023

7

Publications

7

Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia

Vania Manolova, Naja Nyffenegger, Anna Flace et al. · Journal of Clinical Investigation · 2019 · 88 citations · Full text

, , +23

The Adaptor Molecule Nck Localizes the WAVE Complex to Promote Actin Polymerization during CEACAM3-Mediated Phagocytosis of Bacteria

Stefan Pils, Kathrin Kopp, Lisa K. Peterson et al. · PLoS ONE · 2012 · 39 citations · Full text

The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease

Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda et al. · Blood · 2022 · 26 citations · Full text

CcpA Affects Infectivity of Staphylococcus aureus in a Hyperglycemic Environment

Markus Bischoff, Bodo Wonnenberg, Nadine Nippe et al. · Frontiers in Cellular and Infection Microbiology · 2017 · 25 citations · Full text

, , +14

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia

Naja Nyffenegger, Anna Flace, Cédric Doucerain et al. · International Journal of Molecular Sciences · 2021 · 22 citations · Full text

Rows per page

1–5 of 7